Skip to main content

and
Your search also matched 3 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

A Semi-Physiologically Based Pharmacokinetic Model Describing the Altered Metabolism of Midazolam Due to Inflammation in Mice

Include preview-only content
  1. Article

    Open Access

    The parent and family impact of CLN3 disease: an observational survey-based study

    CLN3 disease (also known as CLN3 Batten disease or Juvenile Neuronal Ceroid Lipofuscinosis) is a rare pediatric neurodegenerative disorder caused by biallelic mutations in CLN3. While extensive efforts have been ...

    Angela Schulz, Nita Patel, Jon J. Brudvig, Frank Stehr in Orphanet Journal of Rare Diseases (2024)

  2. Article

    Open Access

    Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2

    The immune responses to Novavax’s licensed NVX-CoV2373 nanoparticle Spike protein vaccine against SARS-CoV-2 remain incompletely understood. Here, we show in rhesus macaques that immunization with Matrix-MTM adju...

    Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, Sebastian Ols in npj Vaccines (2024)

  3. Article

    Open Access

    XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants

    Monovalent SARS-CoV-2 Prototype (Wuhan-Hu-1) and bivalent (Prototype + BA.4/5) COVID-19 vaccines have demonstrated a waning of vaccine-mediated immunity highlighted by lower neutralizing antibody responses aga...

    Nita Patel, Jessica F. Trost, Mimi Guebre-Xabier, Haixia Zhou in Scientific Reports (2023)

  4. Article

    Open Access

    Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants

    SARS-CoV-2 variants have emerged with elevated transmission and a higher risk of infection for vaccinated individuals. We demonstrate that a recombinant prefusion-stabilized spike (rS) protein vaccine based on...

    James Logue, Robert M. Johnson, Nita Patel, Bin Zhou in Nature Communications (2023)

  5. Article

    Open Access

    SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

    The COVID-19 pandemic continues to spread throughout the world with an urgent need for a safe and protective vaccine to effectuate herd protection and control the spread of SARS-CoV-2. Here, we report the deve...

    **g-Hui Tian, Nita Patel, Robert Haupt, Haixia Zhou in Nature Communications (2021)

  6. Article

    Open Access

    The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers

    Little information is available regarding the burden of living with and managing epidermolysis bullosa, including the distinct challenges faced by patients with different disease types/subtypes.

    Anna L. Bruckner, Michael Losow, Jayson Wisk in Orphanet Journal of Rare Diseases (2020)

  7. Article

    Open Access

    Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders

    Rare or orphan diseases often are inherited and overwhelmingly affect children. Many of these diseases have no treatments, are incurable, and have a devastating impact on patients and their families. Regulator...

    Andrew E. Mulberg, Christina Bucci-Rechtweg in Orphanet Journal of Rare Diseases (2019)

  8. Article

    Correction to: A Semi-Physiologically Based Pharmacokinetic Model Describing the Altered Metabolism of Midazolam Due to Inflammation in Mice

    One of the authors has his name incorrectly indexed in PubMed and SpringerLink as “Laird Forrest M” (last name “Laird Forrest”). His name should index as “Forrest M. Laird” with last name as “Forrest”.

    Ninad Varkhede, Nita Patel, William Chang, Kenneth Ruterbories in Pharmaceutical Research (2018)

  9. Article

    Open Access

    Eye Care Quality and Accessibility Improvement in the Community (EQUALITY) for adults at risk for glaucoma: study rationale and design

    Primary open angle glaucoma is a chronic, progressive eye disease that is the leading cause of blindness among African Americans. Glaucoma progresses more rapidly and appears about 10 years earlier in African ...

    Cynthia Owsley, Lindsay A. Rhodes in International Journal for Equity in Health (2015)